EFFICACY AND SAFETY OF USTEKINUMAB INTRAVENOUS INDUCTION IN A COHORT OF PATIENTS WITH CROHN´S DISEASE REFRACTORY TO ANTI-TUMOR NECROSIS FACTOR AGENTS

Aurélia Santoni  1     Mélanie Serrero  1     Romain Altwegg  2     Ariadne Desjeux  1     Lucile Boivineau  2     Jean-Charles Grimaud  1    
1 Hopital Nord,Marseille,France
2 Hôpital Saint Eloi, CHRU Montpellier,Montpellier,France

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing